How Can Registries Contribute to the Development and Evaluation of CNS Therapeutics?

| June 1, 2013 | 0 Comments

by Joanne B. Severe, MS, and Annette Stemhagen, DrPH, FISPE
Ms. Severe is a research consultant in Rockville, Maryland, and Dr. Stemhagen is with United Biosource Corp. in Bethesda, Maryland.

Innov Clin Neurosci. 2013;10(5ā€“6 Suppl A):29Sā€“31S

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , ,

Category: Drug Development, Neurology, Past Articles, Proceedings, Psychiatry, Supplements, Trial Methodology

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.